| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $376.0M | -3.3% |
| R&D Expense | $59.6M | +9.8% |
| SG&A Expense | $103.4M | +8.6% |
| Operating Income | $128.6M | -5.6% |
| Interest Expense | $52.5M | -16.0% |
| Pre-tax Income | $81.2M | +1.5% |
| Income Tax | $16.6M | +31.4% |
| Net Income | $64.6M | -4.1% |
| EPS (Basic) | $0.59 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $78.8M | +44.5% |
| Short-term Investments | $31.6M | +8.8% |
| Accounts Receivable | $34.1M | -13.9% |
| Current Assets | $258.4M | +25.5% |
| Total Assets | $1.10B | -0.7% |
| Current Liabilities | $73.1M | -28.4% |
| Long-term Debt | $475.5M | -18.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $212.5M | +39.1% |
| Capital Expenditures | $1.8M | -52.2% |
| Investing Cash Flow | -$24.0M | +30.3% |
| Financing Cash Flow | -$164.2M | +7.9% |
| Free Cash Flow | $210.6M | +41.4% |
| -6.3% |
| EPS (Diluted) | $0.57 | -5.0% |
| Total Liabilities |
| $701.4M |
| -6.3% |
| Stockholders' Equity | $396.6M | +11.2% |